Pages that link to "Q34658401"
Jump to navigation
Jump to search
The following pages link to Lithium nephrotoxicity revisited (Q34658401):
Displaying 50 items.
- A critical appraisal of treatments for bipolar disorder (Q24613657) (← links)
- Current and future treatment options in SIADH (Q24652519) (← links)
- Drug-Induced Metabolic Acidosis (Q26766204) (← links)
- A novel therapeutic effect of statins on nephrogenic diabetes insipidus (Q27005638) (← links)
- Collecting duct intercalated cell function and regulation (Q27007175) (← links)
- Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder (Q28260681) (← links)
- Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data (Q30957546) (← links)
- The use of lithium carbonate to prevent lomustine-induced myelosuppression in dogs: a pilot study (Q33394758) (← links)
- How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications (Q33602939) (← links)
- Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome (Q33643589) (← links)
- Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment (Q33727794) (← links)
- Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development (Q33904019) (← links)
- Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan (Q34345836) (← links)
- Commentary on a recent review of lithium toxicity: what are its implications for clinical practice? (Q34465856) (← links)
- Tubular transport: core curriculum 2010 (Q34477365) (← links)
- The association of glycogen synthase kinase-3beta (GSK-3β) gene polymorphism with kidney function in long-term lithium-treated bipolar patients (Q34502691) (← links)
- Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders (Q34582543) (← links)
- Effects of chronic lithium administration on renal acid excretion in humans and rats. (Q35094211) (← links)
- Renal failure in lithium-treated bipolar disorder: a retrospective cohort study (Q35132107) (← links)
- Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice (Q35178606) (← links)
- Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus (Q35203675) (← links)
- Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus. (Q35602671) (← links)
- Environmental enrichment rescues postnatal neurogenesis defect in the male and female Ts65Dn mouse model of Down syndrome (Q35661604) (← links)
- Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (Q35754726) (← links)
- Every reason to discontinue lithium (Q35770113) (← links)
- Comparison of three a-priori models in the prediction of serum lithium concentration (Q35890412) (← links)
- Signalling through the type 1 insulin-like growth factor receptor (IGF1R) interacts with canonical Wnt signalling to promote neural proliferation in developing brain (Q36084781) (← links)
- Dual effect of lithium on NFAT5 activity in kidney cells (Q36098316) (← links)
- Attenuation of lithium-induced natriuresis and kaliuresis in P2Y₂ receptor knockout mice (Q36132548) (← links)
- Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice. (Q36289470) (← links)
- P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus. (Q36314883) (← links)
- Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study. (Q36565679) (← links)
- Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. (Q36724058) (← links)
- Lithium: a versatile tool for understanding renal physiology. (Q36836247) (← links)
- Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus (Q37052068) (← links)
- Glycogen synthase kinase-3 regulation of urinary concentrating ability (Q37139392) (← links)
- Lithium Nephrotoxicity: When Is the Time for Nephrology Consultation? (Q37165932) (← links)
- Lithium: a key to the genetics of bipolar disorder (Q37402610) (← links)
- Clinical predictors of nocturia in the sleep apnea population (Q37658115) (← links)
- Aquaporins in kidney pathophysiology (Q37681294) (← links)
- Drugs and pharmaceuticals: management of intoxication and antidotes. (Q37722677) (← links)
- Pharmacologically-induced metabolic acidosis: a review. (Q37732209) (← links)
- Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) (Q37799214) (← links)
- Mechanisms of cell polarity and aquaporin sorting in the nephron (Q37843809) (← links)
- Nocturia as a manifestation of systemic disease (Q37847640) (← links)
- Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders (Q38152961) (← links)
- Lithium for bipolar disorder: a review of the recent literature (Q38240532) (← links)
- Lithium overdosage and related tests. (Q38692610) (← links)
- Global Research Trends in Lithium Toxicity from 1913 to 2015: A Bibliometric Analysis (Q38773415) (← links)
- What we need to know about the effect of lithium on the kidney (Q38819531) (← links)